ABOUT THE EVENT
Date: Wednesday, April 29, 2026 8am–5:45pm EDT
Event Location: Boston, Massachusetts
The Oligonucleotides & Peptides Xchange Boston 2026 brings together senior-level scientists, R&D leaders, and executives from top pharmaceutical and biotechnology organisations for a one-day, high-impact forum dedicated to advancing oligonucleotide and peptide therapeutics. This carefully curated event combines expert presentations, roundtable discussions, pre-booked 1:1 meetings, poster sessions, and dedicated networking breaks — giving attendees abundant opportunity to collaborate, share insights, and solve critical challenges across the value chain.
Topics span the full development spectrum: novel modalities & discovery, drug delivery, CMC and process development, and quality control. Senior experts will address emerging scientific, manufacturing and analytical challenges — from lipid nanoparticles and delivery strategies, through synthesis and purification of peptides/oligos, to scale-up, analytical development, and QC for clinical-grade biomolecules.
With its highly interactive and small-group format, Oligonucleotides & Peptides Xchange is designed to foster real collaboration and breakthrough thinking. Registration is complimentary for eligible senior-level delegates in pharma/biotech with an active drug pipeline.
Don’t miss this unique opportunity to connect with peers, shape the future of oligonucleotide and peptide therapeutics, and drive tangible progress across discovery, development and manufacturing.
Registration is COMPLIMENTARY (for Senior Scientists and above in Bio and Pharma companies with a drug pipeline only).
Date: Thursday, April 30, 2026
Time: 08:00 AM – 05:45 PM
Location: Boston, MA (Woburn)